Funding Rounds
Enterome Series D (2017, $34M)
EnteromeCutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.
Summary
Stage: Series D
Raised Amount: $34.80M
Raised Date: 2017-01-01
Stage: Series D
Raised Amount: $34.80M
Raised Date: 2017-01-01